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Abstract
Background: Smoking cessation treatment service is concerned to be a critical element in methadone
maintenance treatment (MMT) in order to diminish the effect of smoke on health outcomes. To implement the
smoking cessation services in Vietnam, we examined the stages of change to quit and determined associated
factors among MMT patients.
Methods: We conducted a cross-sectional survey with 1016 MMT patients in five clinics in Hanoi and Nam Dinh
province, of those, 932 (91.7 %) were ever-smokers. Patients were classified into four groups: “pre-contemplation,”
“contemplation,” “preparation,” and “action and maintenance” by using the transtheoretical model. Multivariate
logistic regression was applied to determine the associated factor for intention and action to quit smoking.
Results: Overall, 96 % were not actively trying to quit or maintain abstinence. Age older than 45, HIV-positive
status, and residence in Hanoi were negatively associated with intention to quit. Meanwhile, higher levels of
nicotine dependence and number of years of smoking negatively associated with quitting and abstinence.
Conclusions: The study indicated the high rate of MMT smokers being in pre-contemplation stage but low
proportion of quitting and maintaining abstinence. It emphasizes the importance of availability and accessibility of
information about smoking cessation therapies and services. Integrating cessation programs into health-care
services should be considered to provide tailored interventions for different patient groups.
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Background
Improving health status and supporting healthy behav-
iors are the goals of interventions for people who inject
drugs (PWID) [1]. As a country experienced a rapid
spread of HIV infection in drug-using populations,
Vietnam has been implementing a comprehensive harm
reduction strategy [2]. First introduced in 2008, metha-
done maintenance treatment (MMT) service has become
an essential component of the National HIV/AIDS Strat-
egy [2]. Previous studies have shown that MMT is cost-
effective in preventing new HIV cases, improving HIV/
AIDS treatment outcomes, and relieving the economic
burden of HIV/AIDS and substance abuse on both
health systems and affected households [3–5]. MMT,
therefore, is the primary intervention that engages IDU
into harm reduction programs and health-care services.
Although drug-use behaviors significantly changed
over the course of MMT, other unhealthy behaviors may
result in diminished health status and quality of life in
this patient group [6]. Despite decreasing prevalence of
smoking in general population (56 %), it remains high
among MMT patients (from 71 to 98 %) [7–10]. In de-
veloped countries, some MMT programs have instituted
smoking bans, which has reduced the proportion of staff
who smoke but not proportion of patients [11]. Evidence
showed that an interaction between methadone and
nicotine might increase euphoria and diminish mental
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problems such as restlessness, irritability, and depression
[12], by which maintains smoking and reduces patients’
attempts to quit [7]. This interaction is considered a
major cause of morbidity, mortality, disability, and
poorer quality of life among opioid-dependent
smokers compared to non-smokers [13–15]. Therefore,
attention should be paid on smoking among PWID,
and cessation interventions should be encouraged during
MMT [15–18].
Understanding motivation to quit smoking may help
predict success of cessation [19, 20]. This is more im-
portant among drug users who reported much lower
success rate in quitting smoking (12–22 %) than general
population (48–58 %) [7–9, 21–23]. Previous studies
have shown a number of individuals and environmental
factors that influence the process of adapting and main-
taining smoking abstinence among PWID. These factors
included socioeconomic status, mental health problems,
unavailability of health services, family supports, peer in-
fluences, and cultural acceptability [23, 24]. Given its
high variation across settings, empirical evidence of con-
textual factors are necessary to design effective smoking
cessation programs for PWID.
The rapid expansion of MMT services in Vietnam has
provided the treatment to over 30,000 patients [25, 26].
Although the prevalence of smoking among men in
Vietnam was high, however, understanding of smoking
and motivation to quit among MMT patients are still
limited. In this study, we sought to assess patients’ mo-
tivation to quit smoking and its associated factors over
the course of MMT in a multi-site survey.
Methods
Study design and sampling technique
A cross-sectional survey was conducted during January
to August 2013 in two northern provinces: Hanoi and
Nam Dinh. Five MMT clinics were purposely selected
including (1) provincial and district sites, (2) in both
rural and urban areas, and (3) different integrative
models (Table 1). We invited all patients who registered
for MMT at the selected sites to participate in the survey.
Eligibility criteria for recruiting participants included (1)
taking or initiating MMT in selected sites, (2) presenting
at clinics during study period, (3) being 18 years old or
above, (4) having capacity to answer questionnaire, and
(5) agreeing to participate. A total of 1016 patients (91.5 %
response rate) were interviewed, of those, 932 (91.7 %) re-
ported ever smoked that formed the subgroup of this ana-
lysis. In a designated room, face-to-face interviews were
carried out by well-trained investigators using a structured
questionnaire for about 30 min.
Measurements
Variables of interest were selected by adopting the socio-
contextual model of Sorensen et al. for reducing tobacco
use among blue-collar workers [27]. In this study, we
measured the influence of patient- and provider-related
factors on motivation and readiness to quit smoking
among MMT patients.
Socioeconomic status
Socioeconomic factors including age, gender, marital sta-
tus, education, occupation, religion, and income were in-
vestigated. Income per month per capita was computed
by summing all monthly income sources of household,
then dividing to the number of household’s members.
Health-related quality of life
Health status was measured using EQ-5D-5L instru-
ment which showed good measurement properties in
Vietnamese settings [28]. EQ-5D-5L contains five di-
mensions (mobility, self-care, usual activities, pain/dis-
comfort, and anxiety/depression) with five response
levels [29]. In addition, body mass index and HIV sta-
tus were recorded.
Health-care and MMT service utilization
The use of inpatient and outpatient health services
over the past 12 months and duration on MMT were
self-reported.
Substance abuse
To assess alcohol use, we employed a brief version of
the alcohol use disorders identification test-consumption
(AUDIT-C) instrument [30]. The Vietnamese version has
been used in previous studies [31, 32]. It is comprised
of questions with a total score of 0–10. Higher scores
indicate higher risks of alcohol dependence. Hazardous
Table 1 Study settings and sample size
Level Settings Site Name Type of services Sample size
District (rural) Nam Dinh City Provincial AIDS Centre (PAC) MMT + VCT 248
District (rural) Xuan Truong District District Health Centre (DHC) MMT + VCT + ART + GH 128
District (urban) Tu Liem District District Health Centre MMT + VCT + ART + GH 161
District (urban) Long Bien District District Health Centre MMT + VCT + ART + GH 170
District (urban) Ha Dong District Regional Polyclinic (RPC) MMT + GH 196
VCT voluntary HIV testing and counseling, ART antiretroviral treatment, GH general healthcare
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drinkers are identified with the threshold of 4 or above for
men and 3 or above for women [30, 33]. Additionally,
binge drinkers are determined if the respondents have any
positive response to the third question. Illicit drug use be-
haviors included history and current opioid use, duration
of drug use, and the experience of previous drug treatment.
Smoking-related characteristics
To understand the motivation to quit smoking of MMT
patients, we applied the transtheoretical model that de-
scribes the progressing of health behaviors through a
series of five sequential stages of change. This includes (1)
pre-contemplation→ (2) contemplation→ (3) prepar-
ation→ (4) action→ (5) maintenance. We asked the pa-
tients a question: “Are you thinking about quitting
smoking?” with four response levels: “No thought of quit-
ting,” “Think I should quit but not quite ready,” “Starting
to think about how to change my smoking behavior,” and
“Take action to quit” corresponding to the stages of
(1)→ (4). The stage (5) maintenance included those who
have been abstinent of smoking over 6 months.
In addition, the Fagerström test for nicotine depend-
ence (FTND) was used to assess the levels of nicotine
dependence among patients. This instrument contains
six items that yield a total score of 0–10. Higher score
indicates higher level of dependence [34]. Based on the
score, patients were classified into following groups: 0–2:
very low, 3–4: low, 5: moderate, 6–7: high, and 8–10: very
high. Other indicators, including smoking duration,
expenses, and number of cigarettes per days, were also
recorded. In addition, we asked patients who thought of
quitting or cutting down the number of cigarettes they
smoke what measures or supports they would like to
receive to take action and maintain abstinence.
Data analysis
The p value <0.05 was considered statistically signifi-
cance. T test, ANOVA test, and χ [2] were used to meas-
ure the difference between means and proportions. To
identify the determinants of intention and taking action
to quit smoking, we employed multivariate binominal lo-
gistic regression, with fractional polynomial model for
duration of MMT treatment, to assess the non-linear re-
lationships among variables. In addition, backward step-
wise model was approached to include variables with the
threshold of p values of log-likelihood ratio test <0.2.
We then displayed the results by odd ratios (OR) with
corresponding 95 % CI. Data analysis was performed by
using STATA software version 12.0 (Stata Corp. LP,
College Station, United States of America).
Ethical approval
This study was approved by the Vietnam Authority of
HIV/AIDS Control’s Scientific Research Committee.
Written informed consents were collected before start-
ing the interview. Respondents could withdraw from the
study at any time. The information of patients was
coded to ensure confidentiality.
Results
Of 932 respondents, the mean age of sample was
36.5 years (SD = 7.4). The predominant groups were
male (98.8 %), with a religious orientation of cult of an-
cestors (88.7 %), and living with spouse/partner (66.7 %).
Most of the respondents attained less than high school
(54.3 %) and had employment (74.3 %). The majority of
the participants had income more than 2.5 million VND
per month (43.6 %) (Table 2). Table 2 also shows the
health status and health-care utilization of patients.
There were 7.9 % of respondents who were HIV-positive
and 6.3 % currently taking ART medication. Based on
the EQ-5D-5L, about one fifth of sample reported anxiety/
depression (20.2 %) and 17.1 % felt pain/discomfort.
About 22 % had used outpatient health-care service in the
last 12 months, while 8.3 % used inpatient services.
Table 3 indicates substance-use behaviors among
MMT patients. More than a half of respondents smoked
over 10 cigarettes per day. The proportions of people
smoking within 5 min of waking and even if sick in bed
were 32.8 and 0.9 %, respectively. About half of respon-
dents reported a moderate to very high levels of nicotine
dependence. The mean age of initial smoking were 17.2
(SD = 3.5), and the mean duration of smoking was 14.1
years (SD = 8.5). On average, participants spent 300
thousand Vietnam dong (~USD 15, 2013 exchange rate)
monthly for tobacco.
Table 3 also shows that the mean age of initial drug
use was 24.4 years (SD = 6.5). There were 74.7 % respon-
dents ever injected drug, and 4.8 % of patients were con-
currently using opiates during MMT. Most of the
samples had one to five episodes of drug rehabilitation
(66.0 %). As for alcohol use, the prevalence of hazard
and binge drinking was 57.1 and 53.5 %, respectively.
There was only 4 % currently taking actions to quit
smoking, meanwhile 22.1 % were in preparation stage
and 22.8 % were in contemplation stage where they
thought of quitting. In Table 4, preference for cessation
supports were explored among those who were aware of
the harms of smoking (n = 455). Of 423 responses
(93 %), self-administration without others’ supports was
the most preferable approach for smoking cessation
among MMT smokers (77.6 %), followed by using nico-
tine replacement therapy (11.3 %) and having familial
(5 %) and health workers’ (4.5 %) supports.
Results from reduced multivariate logistic regression
are shown in Table 5. The intention to quit smoking of
MMT patients was negatively associated with age older
than 45, HIV-positive status, and residence in Hanoi,
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Table 2 Demographic, health status, and health-care utilization of respondents
Pre-contemplation Contemplation Preparation Action and Maintenance Total p
n % n % n % n % n %
Total 477 51.2 212 22.8 206 22.1 37 4.0 932 100.0
Mean SD Mean SD Mean SD Mean SD Mean SD
Age 37.0 7.7 36.1 7.3 36.0 6.7 35.3 7.0 36.5 7.4 0.19
Sex (male) 473 99.2 212 100.0 202 98.1 34 91.9 921 98.8 <0.01
Marital status
Single/divorced/widow 160 33.5 61 28.8 78 37.9 11 29.7 310 33.3 0.25
Live with spouse/partner 317 66.5 151 71.2 128 62.1 26 70.3 622 66.7
Educational attainment
<High school 277 58.1 114 54.0 91 44.4 23 62.2 505 54.3 <0.01
High school 177 37.1 85 40.3 90 43.9 12 32.4 364 39.1
>High school 23 4.8 12 5.7 24 11.7 2 5.4 61 6.6
Employment
Unemployed 131 27.5 59 27.8 39 18.9 11 29.7 240 25.8 0.09
Currently working 346 72.5 153 72.2 167 81.1 26 70.3 692 74.3
Religion
Cult of ancestors 428 89.7 188 88.7 180 87.4 31 83.8 827 88.7 0.62
Others 49 10.3 24 11.3 26 12.6 6 16.2 105 11.3
Income per capita
<1.2 million VND 101 21.2 48 22.6 38 18.5 7 18.9 194 20.8 0.55
1.2–2.5 million VND 160 33.5 72 34.0 86 41.8 14 37.8 332 35.6
>2.5 million VND 216 45.3 92 43.4 82 39.8 16 43.2 406 43.6
Location
Nam Dinh 313 65.6 117 55.2 104 50.5 14 37.8 548 58.8 <0.01
Hanoi 164 34.4 95 44.8 102 49.5 23 62.2 384 41.2
Area of clinics
Rural 60 12.6 32 15.1 31 15.1 8 21.6 131 14.1 0.40
Urban 417 87.4 180 84.9 175 85.0 29 78.4 801 85.9
MMT model
MMT + VCT 104 21.8 63 29.7 71 34.5 15 40.5 253 27.2 <0.01
MMT + GH 111 23.3 34 16.0 50 24.3 5 13.5 200 21.5
MMT + VCT + GH + ART 262 54.9 115 54.3 85 41.3 17 46.0 479 51.4
Health-related status
Body mass index
Normal weight 366 76.7 151 71.2 152 73.8 28 75.7 697 74.8 0.57
Underweight 28 5.9 19 9.0 13 6.3 4 10.8 64 6.9
Overweight, obesity 83 17.4 42 19.8 41 19.9 5 13.5 171 18.4
HIV-positive 47 9.9 10 4.7 12 5.8 5 13.5 74 7.9 0.04
Current taking ART 36 7.6 9 4.3 10 4.9 4 10.8 59 6.3 0.42
Currently feeling pain 83 17.4 32 15.1 40 19.4 4 10.8 159 17.1 0.49
Currently feeling anxiety/depression 89 18.7 35 16.5 57 27.7 7 18.9 188 20.2 0.02
Health-care services utilization in the last 12 month
Outpatient service utilization 85 17.8 57 26.9 53 25.7 11 29.7 206 22.1 0.01
Inpatient service utilization 43 9.0 19 9.0 14 6.8 1 2.7 77 8.3 0.46
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while positively associated with having outpatient
health-care services in the last 12 months. As for quit-
ting and maintenance, we found that the level of nico-
tine dependence and longer years of smoking negatively
predicted quitting and maintaining abstinence among
MMT patients. In these models, the duration on MMT
has been treated as a polynomial factor that showed a
negative association between the number of months on
MMT and the likelihood of smoking abstinence; how-
ever, it was not statistically significant.
Discussion
This is the first study investigating factors associated
with the motivation of MMT patients to quit smoking in
Table 3 Smoking, nicotine dependence and other substance abuse
Pre-
contemplation
Contemplation Preparation Action and
maintenance
Total p
n % n % n % n % n %
Smoking
Number of cigarettes per day
≤10 215 46.9 101 47.6 85 41.7 13 59.1 414 46.2 0.64
≥11–20 206 45.0 99 46.7 98 48.0 8 36.4 411 45.9
21–30 24 5.2 8 3.8 16 7.8 1 4.6 49 5.5
>30 13 2.8 4 1.9 5 2.5 0 0.0 22 2.5
Smoke within 5 min of waking 156 33.7 57 27.0 79 38.4 9 24.3 301 32.8 0.13
Smoke even if sick in bed 146 32.3 68 32.7 57 28.1 7 19.4 278 30.9 0.30
Nicotine dependence level
Very low 129 27.0 64 30.2 49 23.8 21 56.8 263 28.2 <0.01
Low 130 27.3 51 24.1 58 28.2 7 18.9 246 26.4
Moderate 65 13.6 29 13.7 23 11.2 2 5.4 119 12.8
High 93 19.5 53 25.0 36 17.5 5 13.5 187 20.1
Very high 60 12.6 15 7.1 40 19.4 2 5.4 117 12.6
Mean SD Mean SD Mean SD Mean SD Mean SD
Age at smoking initiation 17.02 3.4 17.05 3.7 17.87 3.4 17.49 2.9 17.24 3.5 0.02
Duration of regular smoking in years 14.41 8.9 13.15 8.3 14.88 7.7 10.49 7.6 14.07 8.5 <0.01
Expense for smoking (thousand VND per month) 302.26 312.5 289.59 272.5 310.03 259.1 140.59 185.2 294.68 289.6 <0.01
FTND score 4.36 2.5 4.22 2.3 4.67 2.6 2.89 2.5 4.34 2.5 <0.01
Drug use
Ever inject drug 369 77.4 143 67.5 160 77.7 24 64.9 696 74.7 0.02
Current drug use 24 5.0 8 3.8 12 5.8 1 2.7 45 4.8 0.71
# drug rehabilitation
None 35 7.3 17 8.0 15 7.3 2 5.4 69 7.4 0.71
1–5 episodes 307 64.4 147 69.3 133 64.6 28 75.7 615 66.0
6–10 108 22.6 36 17.0 47 22.8 4 10.8 195 20.9
>10 27 5.7 12 5.7 11 5.3 3 8.1 53 5.7
Mean SD Mean SD Mean SD Mean SD Mean SD
Age at first drug use 24.49 6.6 24.18 7.0 24.32 6.1 24.24 6.0 24.37 6.5 0.95
Age at first drug injection 27.06 7.6 26.13 6.6 26.94 7.1 25.25 5.4 26.78 7.2 0.41
Time since 1st drug use 13.55 5.9 12.88 5.9 12.70 5.2 12.03 5.3 13.15 5.7 0.14
Time since 1st drug injection 10.40 5.0 9.99 4.9 9.69 4.8 10.00 4.0 10.14 4.9 0.46
Duration of MMT (month) 17.10 11.0 16.83 11.2 14.57 10.0 13.56 9.3 16.34 10.8 0.02
Alcohol use
Hazard Drinking (n = 480) 130 56.3 72 59.0 62 56.9 10 55.6 274 57.1 0.97
Binge Drinking (n = 480) 124 53.7 63 51.6 59 54.1 11 61.1 257 53.5 0.89
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Vietnam. Using the transtheoretical model, we charac-
terized the stages that MMT patients are in with regard
to their smoking behaviors. The findings showed a sub-
stantial proportion of MMT patients were at the pre-
contemplation stage. They did not have any intention to
change their smoking behaviors. It is important to note
that intentions to quit and taking action to quit smoking
were not improved over the course of MMT.
In this study, 44.9 % respondents were in the contem-
plation and preparation stages and only 4.0 % took ac-
tion to quit smoking and maintained abstinence. These
figures were lower than previous studies in MMT pa-
tients. For example, a study of Nahvi et al. showed that
48 % of MMT smokers were in contemplation stage and
22 % were in preparation stage [9]. Another study of
Richter et al. suggested that 46 % of MMT patients were
in contemplation stage [35]. Since having an intention to
Table 4 Preference for support among MMT patients who
thought of smoking cessation
Cessation support Number Percent
Health staff support 19 4.5
Family support 21 5.0
Friend/peer support 6 1.4
Using nicotine replacement therapy 48 11.3
Using herbs 2 0.5
Using acupuncture 1 0.2
Use mobile phone 1 0.2
Self-help 325 76.8
Table 5 Factors associated with Intention to quit and quitting smoking
Intention to quit Quitting smoking
OR 95 % CI OR 95 % CI
Province (Hanoi vs Nam Dinh) 0.47*** 0.34 0.67 0.50* 0.23 1.08
Location (Urban vs Rural) 1.44 0.90 2.31
Duration of MMT (month) 1.00 0.99 1.02 0.99 0.95 1.03
Outpatient service use last 12 months (yes vs no) 1.98*** 1.44 2.72
# of drug rehabilitation 1.03 0.98 1.07
Religion (vs cult of ancestors)
Buddhism 2.72* 0.84 8.78
Occupation (vs unemployed)
Other jobs 1.41 0.87 2.28
Age (vs 18–<25)
35–<40 2.63** 1.30 5.30
≥45 0.51*** 0.34 0.78
Marital status (vs single)
Live with spouse 1.23 0.91 1.67
Income quintile (vs poorest)
Rich 0.78 0.56 1.09
Having pain/discomfort (yes vs no) 0.41 0.12 1.43
HIV status (vs negative)
Positive 0.58** 0.34 0.99
Body mass index (vs underweight)
Normal 1.47 0.86 2.52
Level of nicotine dependence (vs very low)
Low 0.31** 0.12 0.81
Moderate 0.22** 0.05 0.97
High 0.37** 0.13 1.04
Very high 0.22** 0.05 0.99
Year of smoking 0.95** 0.91 1.00
*p < 0.1; **p < 0.05; *** p < 0.01
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quit smoking may predict successful smoking abstinence
[36], the low rate of intention to quit smoking in the
present study may reflect the lack of smoking cessation
interventions and antismoking campaigns targeting this
population. For MMT patients, as illicit drug use is
highly stigmatized in Vietnam, it is likely that their focus
is on opiate absences and do not view cessation of to-
bacco use as a priority. Moreover, smoking is normative
among men in Vietnam with over half of the adult male
population currently smoking.
Literatures documented that patients might suffer
from withdrawal problems (stress/anxiety or other men-
tal problems) while attempting to quit smoking [37] due
to nicotine dependence [38]. In our study, higher level of
nicotine dependence and number of years of smoking
were negative predictors of patient’s abstinence to smok-
ing [39, 40]. This is similar to findings by John et al. who
also suggested that nicotine dependence may increase
the number of quit attempt but decrease the likelihood
of abstinence [38]. As for preferred supports for smoking
cessation, the majority of respondents chose self-
administration while having cessation-related health was
very limited. It may be because of the unawareness of
smokers and unavailability of smoking cessation services
as well as other socioeconomic barriers [41].
Noticeably, the duration of MMT was inversely related
to the intention, although this association was not
statistical significance. To date, prior studies have not
examined this association. Since the duration of MMT
treatment was proportionate with the reduction of MMT
doses, patients with lower doses of methadone were more
likely to report quit intensions [9]. Additional research to
investigate the interaction between duration of MMT and
MMT doses on readiness to quit smoking is warranted.
This study suggested several implications. First, clini-
cians should understand MMT patients’ stage of change
for smoking cessation in order to implement tailored
counseling and interventions. They should first ask
about smoking in MMT clients, then ask about their
interest in quitting. Patients who report no interest
should be counseled using motivational interviewing
about dangers of smoking and ability for people to quit.
Those who express interest should be provided with a
brief smoking cessation intervention, the “five A’s,” in-
cluding ask, advise, assess, assist, and arrange [42].
These tailored clinical interventions should be coupled
with community level interventions [41]. Second, pro-
viding smoking cessation treatment by integrating into
MMT clinics (on-site program) may encourage the mo-
tivation for smoking cessation. Besides, for those
smokers taking antiretroviral therapies, intervening on
smoking may also improve treatment adherence and
outcomes [43]. Finally, capacity of health staffs in terms
of screening and counseling should be enhanced by
training, which helps to enhance the provision of smok-
ing cessation treatment [41].
The strengths of this study included a large sample of
MMT patients in various Vietnamese settings. In addition,
we employed several measures (EQ-5D-5L, FTND,
AUDIT-C) that showed good measurement properties in
these patient groups in Vietnam [3, 28, 31, 32, 44, 45].
Nonetheless, some limitations should be acknowledged.
First, causal relationships between motivation to quit and
related factors cannot be established due to the cross-
sectional design. Second, data collection was based on
self-reports, which might lead to recall bias. Finally, some
psychosocial factors such as methadone dose, self-efficacy,
depression, tobacco availability, social norms, and
smoking cost data were not collected, suggesting the
further research to investigate those factors in order
to better understand the mechanism of smoking be-
haviors and develop appropriate interventions.
Conclusions
In conclusion, the study indicated the high rate of MMT
smokers being in pre-contemplation stage but low
proportion of quitting and abstinence. This study also
underlined the importance of availability and accessibility
of information about smoking cessation therapies with the
high-quality consultation and services. Integrating ces-
sation programs into health-care services should be
considered to provide tailored interventions for different
patient groups.
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